MicroRNAs regulate ocular neovascularization

Jikui Shen, Xiaoru Yang, Bing Xie, Yangjian Chen, Mara Swaim, Sean F. Hackett, Peter A Campochiaro

Research output: Contribution to journalArticle

Abstract

In this study, we used ischemia-induced retinal neovascularization (NV) as a model to investigate the possible role of microRNAs in a clinically important disease process. Microarray analysis demonstrated seven microRNAs (miR-106a, -146, -181, -199a, -214, -424, and -451) that were substantially increased and three microRNAs (miR-31, -150, and -184) that were substantially decreased in ischemic retina. Potential targets for the upregulated microRNAs were not identified, but bioinformatic analysis suggested target genes for the downregulated microRNAs, and these were confirmed using a luciferase reporter assay. Real-time reverse transcriptase PCR confirmed that the substantial levels of miR-31, -150, and -184 present in normal retina were significantly reduced in ischemic retina. Interestingly, constitutive levels of miR-31 and -184 are high in the cornea and lens, two avascular tissues. Intraocular injection of pre-miR-31, -150, or -184 significantly reduced ischemia-induced retinal NV, and injection of pre-miR-31 or -150 also significantly reduced choroidal NV. These data suggest that alteration of microRNA levels contributes to two types of ocular NV, and that injection or enhanced expression of microRNAs is a potential therapeutic strategy.

Original languageEnglish (US)
Pages (from-to)1208-1216
Number of pages9
JournalMolecular Therapy
Volume16
Issue number7
DOIs
StatePublished - Jul 2008

Fingerprint

MicroRNAs
Retinal Neovascularization
Retina
Ischemia
Intraocular Injections
Choroidal Neovascularization
Injections
Microarray Analysis
Computational Biology
Luciferases
Reverse Transcriptase Polymerase Chain Reaction
Cornea
Lenses
Real-Time Polymerase Chain Reaction
Down-Regulation
Genes

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Shen, J., Yang, X., Xie, B., Chen, Y., Swaim, M., Hackett, S. F., & Campochiaro, P. A. (2008). MicroRNAs regulate ocular neovascularization. Molecular Therapy, 16(7), 1208-1216. https://doi.org/10.1038/mt.2008.104

MicroRNAs regulate ocular neovascularization. / Shen, Jikui; Yang, Xiaoru; Xie, Bing; Chen, Yangjian; Swaim, Mara; Hackett, Sean F.; Campochiaro, Peter A.

In: Molecular Therapy, Vol. 16, No. 7, 07.2008, p. 1208-1216.

Research output: Contribution to journalArticle

Shen, J, Yang, X, Xie, B, Chen, Y, Swaim, M, Hackett, SF & Campochiaro, PA 2008, 'MicroRNAs regulate ocular neovascularization', Molecular Therapy, vol. 16, no. 7, pp. 1208-1216. https://doi.org/10.1038/mt.2008.104
Shen J, Yang X, Xie B, Chen Y, Swaim M, Hackett SF et al. MicroRNAs regulate ocular neovascularization. Molecular Therapy. 2008 Jul;16(7):1208-1216. https://doi.org/10.1038/mt.2008.104
Shen, Jikui ; Yang, Xiaoru ; Xie, Bing ; Chen, Yangjian ; Swaim, Mara ; Hackett, Sean F. ; Campochiaro, Peter A. / MicroRNAs regulate ocular neovascularization. In: Molecular Therapy. 2008 ; Vol. 16, No. 7. pp. 1208-1216.
@article{cd352868c4e2437d906b083b1a4195f9,
title = "MicroRNAs regulate ocular neovascularization",
abstract = "In this study, we used ischemia-induced retinal neovascularization (NV) as a model to investigate the possible role of microRNAs in a clinically important disease process. Microarray analysis demonstrated seven microRNAs (miR-106a, -146, -181, -199a, -214, -424, and -451) that were substantially increased and three microRNAs (miR-31, -150, and -184) that were substantially decreased in ischemic retina. Potential targets for the upregulated microRNAs were not identified, but bioinformatic analysis suggested target genes for the downregulated microRNAs, and these were confirmed using a luciferase reporter assay. Real-time reverse transcriptase PCR confirmed that the substantial levels of miR-31, -150, and -184 present in normal retina were significantly reduced in ischemic retina. Interestingly, constitutive levels of miR-31 and -184 are high in the cornea and lens, two avascular tissues. Intraocular injection of pre-miR-31, -150, or -184 significantly reduced ischemia-induced retinal NV, and injection of pre-miR-31 or -150 also significantly reduced choroidal NV. These data suggest that alteration of microRNA levels contributes to two types of ocular NV, and that injection or enhanced expression of microRNAs is a potential therapeutic strategy.",
author = "Jikui Shen and Xiaoru Yang and Bing Xie and Yangjian Chen and Mara Swaim and Hackett, {Sean F.} and Campochiaro, {Peter A}",
year = "2008",
month = "7",
doi = "10.1038/mt.2008.104",
language = "English (US)",
volume = "16",
pages = "1208--1216",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - MicroRNAs regulate ocular neovascularization

AU - Shen, Jikui

AU - Yang, Xiaoru

AU - Xie, Bing

AU - Chen, Yangjian

AU - Swaim, Mara

AU - Hackett, Sean F.

AU - Campochiaro, Peter A

PY - 2008/7

Y1 - 2008/7

N2 - In this study, we used ischemia-induced retinal neovascularization (NV) as a model to investigate the possible role of microRNAs in a clinically important disease process. Microarray analysis demonstrated seven microRNAs (miR-106a, -146, -181, -199a, -214, -424, and -451) that were substantially increased and three microRNAs (miR-31, -150, and -184) that were substantially decreased in ischemic retina. Potential targets for the upregulated microRNAs were not identified, but bioinformatic analysis suggested target genes for the downregulated microRNAs, and these were confirmed using a luciferase reporter assay. Real-time reverse transcriptase PCR confirmed that the substantial levels of miR-31, -150, and -184 present in normal retina were significantly reduced in ischemic retina. Interestingly, constitutive levels of miR-31 and -184 are high in the cornea and lens, two avascular tissues. Intraocular injection of pre-miR-31, -150, or -184 significantly reduced ischemia-induced retinal NV, and injection of pre-miR-31 or -150 also significantly reduced choroidal NV. These data suggest that alteration of microRNA levels contributes to two types of ocular NV, and that injection or enhanced expression of microRNAs is a potential therapeutic strategy.

AB - In this study, we used ischemia-induced retinal neovascularization (NV) as a model to investigate the possible role of microRNAs in a clinically important disease process. Microarray analysis demonstrated seven microRNAs (miR-106a, -146, -181, -199a, -214, -424, and -451) that were substantially increased and three microRNAs (miR-31, -150, and -184) that were substantially decreased in ischemic retina. Potential targets for the upregulated microRNAs were not identified, but bioinformatic analysis suggested target genes for the downregulated microRNAs, and these were confirmed using a luciferase reporter assay. Real-time reverse transcriptase PCR confirmed that the substantial levels of miR-31, -150, and -184 present in normal retina were significantly reduced in ischemic retina. Interestingly, constitutive levels of miR-31 and -184 are high in the cornea and lens, two avascular tissues. Intraocular injection of pre-miR-31, -150, or -184 significantly reduced ischemia-induced retinal NV, and injection of pre-miR-31 or -150 also significantly reduced choroidal NV. These data suggest that alteration of microRNA levels contributes to two types of ocular NV, and that injection or enhanced expression of microRNAs is a potential therapeutic strategy.

UR - http://www.scopus.com/inward/record.url?scp=45749088930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45749088930&partnerID=8YFLogxK

U2 - 10.1038/mt.2008.104

DO - 10.1038/mt.2008.104

M3 - Article

C2 - 18500251

AN - SCOPUS:45749088930

VL - 16

SP - 1208

EP - 1216

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 7

ER -